Metabolic effects of growth hormone (GH) replacement in children and adolescents with severe isolated GH deficiency due to a GHRH receptor mutation

Clinical Endocrinology

Volumn 66, Issue 4, 2007, Pages 466-474

  Gleeson, Helena ^a   Barreto, Elenilde S De A ^b   Salvatori, Roberto ^c   Costa, Liana ^b   Oliveira, Carla R P ^b   Pereira, Rossana M C ^b   Clayton, Peter ^d   Aguiar Oliveira, Manuel H ^b  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GROWTH HORMONE RELEASING FACTOR RECEPTOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUMAN GROWTH HORMONE; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADOLESCENT; ARTICLE; BODY COMPOSITION; BODY MASS; BRAZIL; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MALE; METABOLISM; PHYSICAL DEVELOPMENT; PRIORITY JOURNAL; PUBERTY; RURAL POPULATION;

ADOLESCENT; ANALYSIS OF VARIANCE; BODY COMPOSITION; CASE-CONTROL STUDIES; CHILD; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; GENE DELETION; GROWTH DISORDERS; GROWTH HORMONE; HEMOGLOBIN A, GLYCOSYLATED; HOMOZYGOTE; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MUTATION; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 33947266119     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2007.02753.x     Document Type: Article

References (45)

1. De Boer, H., Blok, G.J. & Van Der Veen, E.A. (1995) Clinical aspects of growth hormone deficiency in adults. Endocrine Reviews, 16, 63-86.
2. Attanasio, A.F., Howell, S., Bates, P.C., Frewer, P., Chipman, J., Blum, W.F. & Shalet, S.M. (2002) Body composition, IGF-I and IGFBP-3 concentrations as outcome measures in severely GH-deficient (GHD) patients after childhood GH treatment: a comparison with adult onset GHD patients. Journal of Clinical Endocrinology and Metabolism, 87, 3368-3372.
3. Attanasio, A.F., Shavrikova, E., Blum, W.F., Cromer, M., Child, C.J., Paskova, M., Lebl, J., Chipman, J.J. & Shalet, S.M. (2004) Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients. Journal of Clinical Endocrinology and Metabolism, 89, 4857-4862.
4. Johannsson, G., Albertsson-Wikland, K. & Bengtsson, B.A. (1999) Discontinuation of growth hormone (GH) treatment: metabolic effects in GH-deficient and GH-sufficient adolescent patients compared with control subjects. Swedish Study Group for Growth Hormone Treatment in Children. Journal of Clinical Endocrinology and Metabolism, 84, 4516-4524.
5. Vahl, N., Juul, A., Jorgensen, J.O., Orskov, H., Skakkebaek, N.E. & Christiansen, J.S. (2000) Continuation of growth hormone (GH) replacement in GH-deficient patients during transition from childhood to adulthood: a two-year placebo-controlled study. Journal of Clinical Endocrinology and Metabolism, 85, 1874-1881.
6. Norrelund, H., Vahl, N., Juul, A., Moller, N., Alberti, K.G., Skakkebaek, N.E., Christiansen, J.S. & Jorgensen, J.O. (2000) Continuation of growth hormone (GH) therapy in GH-deficient patients during transition from childhood to adulthood: impact on insulin sensitivity and substrate metabolism. Journal of Clinical Endocrinology and Metabolism, 85, 1912-1917.
7. Carroll, P.V., Drake, W.M., Maher, K.T., Metcalfe, K., Shaw, N.J., Dunger, D.B., Cheetham, T.D., Camacho-Hubner, C., Savage, M.O. & Monson, J.P. (2004) Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. Journal of Clinical Endocrinology and Metabolism, 89, 3890-3895.
8. Mauras, N., Pescovitz, O.H., Allada, V., Messig, M., Wajnrajch, M.P. & Lippe, B. (2005) Limited efficacy of growth hormone (GH) during transition of GH-deficient patients from adolescence to adulthood: a phase III multicenter, double-blind, randomized two-year trial. Journal of Clinical Endocrinology and Metabolism, 90, 3946-3955.
9. Blackett, P.R., Weech, P.K., McConathy, W.J. & Fesmire, J.D. (1982) Growth hormone in the regulation of hyperlipidemia. Metabolism, 31, 117-120.
10. Boot, A.M., Engels, M.A., Boerma, G.J., Krenning, E.P. & De Muinck Keizer-Schrama, S.M. (1997) Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. Journal of Clinical Endocrinology and Metabolism, 82, 2423-2428.
11. Esposito, V., Di Biase, S., Lettiero, T., Labella, D., Simeone, R. & Salerno, M. (2004) Serum homocysteine concentrations in children with growth hormone (GH) deficiency before and after 12 months GH replacement. Clinical Endocrinology, 61, 607-611.
12. Gacs, G. & Romics, L. (1987) Effect of growth hormone on serum lipoproteins in growth hormone deficiency. Experimental Clinical Endocrinology, 90, 227-231.
13. Heubi, J.E., Burstein, S., Sperling, M.A., Gregg, D., Subbiah, M.T. & Matthews, D.E. (1983) The role of human growth hormone in the regulation of cholesterol and bile acid metabolism. Journal of Clinical Endocrinology and Metabolism, 57, 885-891.
14. Kuromaru, R., Kohno, H., Ueyama, N., Hassan, H.M., Honda, S. & Hara, T. (1998) Long-term prospective study of body composition and lipid profiles during and after growth hormone (GH) treatment in children with GH deficiency: gender-specific metabolic effects. Journal of Clinical Endocrinology and Metabolism, 83, 3890-3896.
15. Kohno, H., Ueyama, N., Yanai, S., Ukaji, K. & Honda, S. (1995) Beneficial effect of growth hormone on atherogenic risk in children with growth hormone deficiency. Journal of Pediatrics, 126, 953-955.
16. Winter, R.J., Thompson, R.G. & Green, O.C. (1979) Serum cholesterol and triglycerides in children with growth hormone deficiency. Metabolism, 28, 1244-1249.
17. Schaefer, G.B., Greger, N.G., Fesmire, J.D., Blackett, P.R., Wilson, D.P. & Frindik, J.P. (1994) Lipids and apolipoproteins in growth hormone-deficient children during treatment. Metabolism, 43, 1457-1461.
18. Hassan, H.M., Kohno, H., Kuromaru, R., Honda, S. & Ueda, K. (1996) Body composition, atherogenic risk factors and apolipoproteins following growth hormone treatment. Acta Paediatrica, 85, 899-901.
19. Elimam, A., Lindgren, A.C., Norgren, S., Kamel, A., Skwirut, C., Bang, P. & Marcus, C. (1999) Growth hormone treatment down-regulates serum leptin levels in children independent of changes in body mass index. Hormone Research, 52, 66-72.
20. Hogler, W., Briody, J., Moore, B., Lu, P.W. & Cowell, C.T. (2005) Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency. Bone, 37, 642-650.
21. Vaisman, N., Zadik, Z., Shamai, Y., Franklin, L. & Dukhan, R. (1992) Changes in body composition of patients with subnormal spontaneous secretion of growth hormone, during the first year of treatment with growth hormone. Metabolism, 41, 483-486.
22. Salvatori, R., Hayashida, C.Y., Aguiar-Oliveira, M.H., Phillips, J.A., 3rd, Souza, A.H., Gondo, R.G., Toledo, S.P., Conceicao, M.M., Prince, M., Maheshwari, H.G., Baumann, G. & Levine, M.A. (1999) Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. Journal of Clinical Endocrinology and Metabolism, 84, 917-923.
23. Gleeson, H.K., Souza, A.H., Gill, M.S., Wieringa, G.E., Barretto, E.S., Barretto-Filho, J.A., Shalet, S.M., Aguiar-Oliveira, M.H. & Clayton, P.E. (2002) Lipid profiles in untreated severe congenital isolated growth hormone deficiency through the lifespan. Clinical Endocrinology, 57, 89-95.
24. De, A.B.E.S., Gill, M.S., De Freitas, M.E., Magalhaes, M.M., Souza, A.H., Aguiar-Oliveira, M.H. & Clayton, P.E. (1999) Serum leptin and body composition in children with familial GH deficiency (GHD) due to a mutation in the growth hormone-releasing hormone (GHRH) receptor. Clinical Endocrinology, 51, 559-564.
25. Freeman, J.V., Cole, T.J., Chinn, S., Jones, P.R., White, E.M. & Preece, M.A. (1995) Cross-sectional stature and weight reference curves for the UK, 1990. Archives of Disease in Childhood, 73, 17-24.
26. Barreto-Filho, J.A., Alcantara, M.R., Salvatori, R., Barreto, M.A., Sousa, A.C., Bastos, V., Souza, A.H., Pereira, R.M., Clayton, P.E., Gill, M.S. & Aguiar-Oliveira, M.H. (2002) Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia. Journal of Clinical Endocrinology and Metabolism, 87, 2018-2023.
27. Castelli, W.P. (1996) Lipids, risk factors and ischaemic heart disease. Atherosclerosis, 124, S1-S9.
28. Trivelli, L.A., Ranney, H.M. & Lai, H.T. (1971) Hemoglobin components in patients with diabetes mellitus. New England Journal of Medicine, 284, 353-357.
29. Brodie, D.A. & Eston, R.G. (1992) Body fat estimations by electrical impedance and infra-red interactance. International Journal of Sports Medicine, 13, 319-325.
30. Fuller, N.J., Dewit, O. & Wells, J.C. (2001) The potential of near infrared interactance for predicting body composition in children. European Journal of Clinical Nutrition, 55, 967-972.
31. Hainline, A., Karon, J. & Lippel, K., eds (1982) Lipid Research Clinics Program: Lipid and Lipoprotein Analysis, 2nd edn. US Department of Health and Human Resources, Bethesda.
32. Maheshwari, H.G., Silverman, B.L., Dupuis, J. & Baumann, G. (1998) Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: dwarfism of Sindh. Journal of Clinical Endocrinology and Metabolism, 83, 4065-4074.
33. Guevara-Aguirre, J., Rosenbloom, A.L., Vaccarello, M.A., Fielder, P.J., de la Vega, A., Diamond, F.B. Jr & Rosenfeld, R.G. (1991) Growth hormone receptor deficiency (Laron syndrome): clinical and genetic characteristics. Acta Paediatrica Scandinavica. Supplement, 377, 96-103.
34. Roelfsema, F., Biermasz, N.R., Veldman, R.G., Veldhuis, J.D., Frolich, M., Stokvis-Brantsma, W.H. & Wit, J.M. (2001) Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. Journal of Clinical Endocrinology and Metabolism, 86, 2459-2464.
35. Maheshwari, H.G., Pezzoli, S.S., Rahim, A., Shalet, S.M., Thorner, M.O. & Baumann, G. (2002) Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. American Journal of Physiology. Endocrinology and Metabolism, 282, 4, E943-4, E951.
36. Van Der Sluis, I.M., Boot, A.M., Hop, W.C., De Rijke, Y.B., Krenning, E.P. & De Muinck Keizer-Schrama, S.M. (2002) Long-term effects of growth hormone therapy on bone mineral density, body composition, and serum lipid levels in growth hormone deficient children: a 6-year follow-up study. Hormone Research, 58, 207-214.
37. Leger, J., Carel, C., Legrand, I., Paulsen, A., Hassan, M. & Czernichow, P. (1994) Magnetic resonance imaging evaluation of adipose tissue and muscle tissue mass in children with growth hormone (GH) deficiency, Turner's syndrome, and intrauterine growth retardation during the first year of treatment with GH. Journal of Clinical Endocrinology and Metabolism, 78, 904-909.
38. Kuromaru, R., Kohno, H. & Hara, T. (2002) Changes in adiposity and excess body weight correlate with growth responses but not with decreases in low-density lipoprotein cholesterol levels during GH treatment in GH-deficient children. Clinical Endocrinology, 56, 799-803.
39. Sas, T., Mulder, P. & Hokken-Koelega, A. (2000) Body composition, blood pressure, and lipid metabolism before and during longterm growth hormone (GH) treatment in children with short stature born small for gestational age either with or without GH deficiency. Journal of Clinical Endocrinology and Metabolism, 85, 3786-3792.
40. Roemmich, J.N., Huerta, M.G., Sundaresan, S.M. & Rogol, A.D. (2001) Alterations in body composition and fat distribution in growth hormone-deficient prepubertal children during growth hormone therapy. Metabolism, 50, 537-547.
41. Oliveira, J.L., Marques-Santos, C., Barreto-Filho, J.A., Filho, R.X., Britto, A.V., Souza, A.H., Prado, C.M., Oliveira, C.R., Pereira, R.M., Vicente, T.D., Farias, C.T., Aguiar-Oliveira, M.H. & Salvatori, R. (2006) Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone deficiency due to a GHRH receptor mutation. Journal of Clinical Endocrinology and Metabolism.
42. Cutfield, W.S., Wilton, P., Bennmarker, H., Albertsson-Wikland, K., Chatelain, P., Ranke, M.B. & Price, D.A. (2000) Incidence of diabetes mellitus and impaired glucose tolerance in children and adolescents receiving growth-hormone treatment. Lancet, 355, 610-613.
43. Clayton, P.E. & Cowell, C.T. (2000) Safety issues in children and adolescents during growth hormone therapy - a review. Growth Hormone and IGF Research, 10, 306-317.
44. Saenger, P., Attie, K.M., Dimartino-Nardi, J. & Fine, R.N. (1996) Carbohydrate metabolism in children receiving growth hormone for 5 years. Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature. Genentech Collaborative Group. Pediatric Nephrology, 10, 261-263.
45. Seminara, S., Merello, G., Masi, S., Filpo, A., La Cauza, F., D'Onghia, G., Martelli, E. & Loche, S. (1998) Effect of long-term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency. Clinical Endocrinology, 49, 125-130.